Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) is a major threat to global TB control. MDR-TB treatment regimens typically have a high pill burden, last 20 months or more and often lead to unsatisfactory outcomes. A 9–11 month regimen with seven antibiotics has shown high success rates among...

Descripción completa

Detalles Bibliográficos
Autores principales: Trauer, James M., Achar, Jay, Parpieva, Nargiza, Khamraev, Atadjan, Denholm, Justin T., Falzon, Dennis, Jaramillo, Ernesto, Mesic, Anita, du Cros, Philipp, McBryde, Emma S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114735/
https://www.ncbi.nlm.nih.gov/pubmed/27855693
http://dx.doi.org/10.1186/s12916-016-0723-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114735/
https://www.ncbi.nlm.nih.gov/pubmed/27855693
http://dx.doi.org/10.1186/s12916-016-0723-2

Ejemplares similares